Results 41 to 50 of about 75,442 (259)

Islets of stability beyond period doubling

open access: yes, 1981
Period doubling of a periodic orbit of an area preserving map appears to lead to the elimination of all closed invariant curves in the vicinity. We show, however, that there are always islets of stabilhty again beyond the accumulation point of the period
Mackay, R.S., R.S. Mackay
core   +1 more source

Stabilizing Ferroresonance Oscillations in Voltage Transformers Using Limiter Circuit

open access: yesElectronics, 2012
This paper employs the multiple scales method and chaos theory for analyzing chaotic behavior of the voltage transformer (VT) with linear core loss model.
Hamid Radmanesh, Seyed Hamid Fathi
doaj   +1 more source

Impact of Climate Change on Irrigation Demand and Crop Growth in a Mediterranean Environment of Turkey

open access: yesSensors, 2007
A simulation study was carried out to describe effects of climate change on cropgrowth and irrigation water demand for a wheat-maize cropping sequence in aMediterranean environment of Turkey. Climate change scenarios were projected using dataof the three
Tomokazu Haraguchi   +2 more
doaj   +1 more source

EDNRB‐dependent endothelin signaling reduces proliferation and promotes proneural‐to‐mesenchymal transition in gliomas

open access: yesMolecular Oncology, EarlyView.
Glioma cells mainly express the endothelin receptor EDNRB, while EDNRA is restricted to a perivascular tumor subpopulation. Endothelin signaling reduces glioma cell proliferation while promoting migration and a proneural‐to‐mesenchymal transition associated with poor prognosis. This pathway activates Ca2+, K+, ERK, and STAT3 signalings and is regulated
Donovan Pineau   +36 more
wiley   +1 more source

Palindromic length sequence of the ruler sequence and of the period-doubling sequence

open access: yes, 2020
In this article, we study the palindromic length sequences of the ruler sequence and of the period-doubling sequence. We give a precise formula of the palindromic length sequence of the first one and find a lower bound of the limit superior of the palindromic length sequence of the last one.
openaire   +2 more sources

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch   +13 more
wiley   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

open access: yesMolecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu   +10 more
wiley   +1 more source

Parametric interaction of modes in the presence of quadratic or cubic nonlinearity [PDF]

open access: yesИзвестия высших учебных заведений: Прикладная нелинейная динамика
The purpose of this work is a study of the dynamics of the systems of ordinary differential equations of the second order, which is obtained using the Lagrange formalism.
Turukina, L. V.
doaj   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy